Lenz Therapeutics' eye disease drugs meet main goal of late-stage study
03/04/2024 12:09
April 3 (Reuters) - Lenz Therapeutics LENZ.O said on Wednesday its experimental drugs to treat loss of near vision met the main goal of a late-stage study. (Reporting by Sneha S K in Bengaluru; Editing by Shilpi Majumdar) ((Sneha.SK@thomsonreuters.com;))